Fractional Erbium-YAG Laser and Platelet-Rich Plasma as Single or Combined Treatment for Atrophic Acne Scars: A Randomized Clinical Trial

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2190-9172
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Fractional Erbium-YAG Laser and Platelet-Rich Plasma as Single or Combined Treatment for Atrophic Acne Scars: A Randomized Clinical Trial ; volume:9 ; number:4 ; day:16 ; month:8 ; year:2019 ; pages:707-717 ; date:12.2019
Dermatology and therapy ; 9, Heft 4 (16.8.2019), 707-717, 12.2019

Creator
El-Taieb, Moustafa A.
Ibrahim, Hassan M.
Hegazy, Eisa M.
Ibrahim, Ahmed K.
Gamal, Aya M.
Nada, Essam A.
Contributor
SpringerLink (Online service)

DOI
10.1007/s13555-019-00318-1
URN
urn:nbn:de:101:1-2020030217471866147231
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • El-Taieb, Moustafa A.
  • Ibrahim, Hassan M.
  • Hegazy, Eisa M.
  • Ibrahim, Ahmed K.
  • Gamal, Aya M.
  • Nada, Essam A.
  • SpringerLink (Online service)

Other Objects (12)

Fluid Platelet-Rich Fibrin (PRF) Versus Platelet-Rich Plasma (PRP) in the Treatment of Atrophic Acne Scars: A Comparative Study

Fluid Platelet-Rich Fibrin (PRF) Versus Platelet-Rich Plasma (PRP) in the Treatment of Atrophic Acne Scars: A Comparative Study

Adapalene 0.3% Gel Shows Efficacy for the Treatment of Atrophic Acne Scars

Adapalene 0.3% Gel Shows Efficacy for the Treatment of Atrophic Acne Scars

Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study

Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study

Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study

Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study

Microneedling combined with botulinum toxin-A versus microneedling combined with platelet-rich plasma in treatment of atrophic acne scars: a comparative split face study

Microneedling combined with botulinum toxin-A versus microneedling combined with platelet-rich plasma in treatment of atrophic acne scars: a comparative split face study

Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey

Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey

Correction to: Microneedling combined with botulinum toxin‑A versus microneedling combined with platelet‑rich plasma in treatment of atrophic acne scars: a comparative split face study

Correction to: Microneedling combined with botulinum toxin‑A versus microneedling combined with platelet‑rich plasma in treatment of atrophic acne scars: a comparative split face study

Clinical Factors Affecting the Effectiveness of 1550-nm Erbium-Doped Fractional Photothermolysis Laser for Individual Atrophic Acne Scar Types

Clinical Factors Affecting the Effectiveness of 1550-nm Erbium-Doped Fractional Photothermolysis Laser for Individual Atrophic Acne Scar Types

New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

Platelet-Rich Plasma Injection in Patients with Atrophic Rhinitis

Platelet-Rich Plasma Injection in Patients with Atrophic Rhinitis

Erratum to: New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

Erratum to: New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

Platelet-rich plasma as an adjuvant therapy to fractional ablative carbon dioxide lasers for cutaneous repair: a complementary treatment for atrophic acne scarring

Platelet-rich plasma as an adjuvant therapy to fractional ablative carbon dioxide lasers for cutaneous repair: a complementary treatment for atrophic acne scarring

Related objects